Effect of BEMER magnetic field therapy on the level of fatigue in patients with multiple sclerosis: A randomized, double-blind controlled trial

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 5, 2009, Pages 507-511

  Piatkowski, Joachim ^a   Kern, Simone ^b   Ziemssen, Tjalf ^b  

^a Neurological Outpatient Center Reichenbachstrasse   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELECTROMAGNETIC FIELD; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LONG TERM CARE; MAGNETOTHERAPY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHAM PROCEDURE; THERAPY EFFECT;

ADULT; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEVERITY OF ILLNESS INDEX;

EID: 67149133505     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0501     Document Type: Article

References (25)

1. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984;65:135-138.
2. Fisk JD, Pontefract A, Ritvo PG, et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994;21:9-14.
3. Ziemssen T. Multiple sclerosis beyond EDSS: Fatigue and depression. J Neurol Sci 2008;273:S32-S35.
4. Vercoulen JH, et al. The measurement of fatigue in patients with multiple sclerosis: A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996;53:642-649.
5. Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Multiple Sclerosis 2005;11:602-609.
6. Krupp LB. Fatigue in multiple sclerosis: Definition, pathophysiology and treatment. CNS Drugs 2003;17:225-234.
7. Jackson MF, Quaal C, Reeves MA. Effects of multiple sclerosis on occupational and career patterns. Axone 1991;13:16-17, 20-12.
8. Bakshi R. Fatigue associated with multiple sclerosis: Diagnosis, impact and management. Multiple Sclerosis 2003;9:219-227.
9. Filippi M, Rocca MA. Toward a definition of structural and functional MRI substrates of fatigue in multiple sclerosis. J Neurol Sci 2007;263:1-2.
10. Lee D, Newell R, Ziegler L, Topping A. Treatment of fatigue in multiple sclerosis: A systematic review of the literature. Int J Nurs Pract 2008;14:81-93.
11. Ziemssen T, Hoffmann J, Apfel R, Kern S. Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis. Health Quality Life Outcomes 2008;6:67.
12. Neill J, Belan I, Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: A systematic review. J Adv Nurs 2006;56:617-635.
13. Richards TL, et al. Double-blind study of pulsing magnetic field effects on multiple sclerosis. J Altern Complement Med 1997;3:21-29.
14. Lappin MS, Lawrie FW, Richards TL, Kramer ED. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: A double-blind, placebo controlled trial. Altern Ther Health Med 2003;9:38-48.
15. Mostert S, Kesselring J. Effect of pulsed magnetic field therapy on the level of fatigue in patients with multiple sclerosis: A randomized controlled trial. Multiple Sclerosis 2005;11:302-305.
16. Sandyk R. Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis. Int J Neurosci 1996;84:177-186.
17. Sandyk R. Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. Int J Neurosci 1997;90:59-74.
18. Walther M, Mayer F, Kafka W, Schutze N. Effects of weak, low-frequency pulsed electromagnetic fields (BEMER type) on gene expression of human mesenchymal stem cells and chondrocytes: An in vitro study. Electromagnetic Biol Med 2007;26:179-190.
19. Poser CM. Clinical diagnostic criteria in epidemiological studies of multiple sclerosis. Ann NY Acad Sci 1965;122:506-519.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
21. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Washington, DC: Paralyzed Veterans of America, 1998:1-33.
22. Hautzinger M. Die CES-D Skala: A depression scale for evaluation of general populations [in German]. Diagnostika 1988;34:167-173.
23. Nielsen JF, Sinkjaer T. Long-lasting depression of soleus motoneurons excitability following repetitive magnetic stimuli of the spinal cord in multiple sclerosis patients. Multiple Sclerosis 1997;3:18-30.
24. Sandyk R. Resolution of sleep paralysis by weak electromagnetic fields in a patient with multiple sclerosis. Int J Neurosci 1997;90:145-157.
25. Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Multiple Sclerosis 2002;8:161-168.